


Limitations on direct personal contact and physical (social) distancing have influenced access to care. Elective interventions and surgical procedures in most European countries have been postponed and operating room resources have been diverted to manage the pandemic. The COVID-19 pandemic has resulted in diversion of healthcare resources including workforce, critical supplies, emergency, and intensive care unit (ICU) facilities to the management of patients infected with SARS-CoV-2 virus. However, the demand for home medical devices has been increasing as there is fear of COVID-19 infection outside. Resulting from these situations, the regional government has announced the local restrictions in countries and ordered them to follow the lockdown rules. Spain, Italy, Germany, France, and the UK are among the most affected European countries. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Such rising incidence rates of diabetes and other related chronic diseases, in turn, increases the patient pool, which drives the compression therapy market growth. The growth of the market is attributed by the increasing incidence of diabetes increases the internal risk factors such as swelling of legs, ankles, and feet, which will lead to venous disorders. Europe occupies a significant position in the global home sequential compression devices market and is expected to record vigorous growth rate during the forecast period. The Europe home sequential compression devices market includes the consolidated markets for France, Germany, United Kingdom, Spain, Italy, and Rest of Europe.
